REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Contract Award

Mycelx TechnologiesAnnouncement

11/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230711:nRSK6252Fa&default-theme=true

RNS Number : 6252F  MyCelx Technologies Corporation  11 July 2023

11 July 2023

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Contract Award

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology company, is pleased to announce the award of a
contract extension for wastewater treatment at a leading independent
petrochemical facility in the Middle East.

 

This contract, together with the award announced on 3(rd) July 2023 for
wastewater treatment in the Middle East, will generate revenue in aggregate in
excess of $2 million in 2023 across the two contracts and helps underpin the
current market forecast for the current year.

 

Connie Mixon, CEO, commented:

 

"Our technology and expertise continue to provide customers with effective
solutions for treating complex process water. Maintaining the high level of
performance that our customers require is extremely important to us and sets
us apart from competitors."

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                  Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity Limited (Nomad and Sole Broker)

 Henry Fitzgerald-O'Connor                          Tel: +44 20 7523 8000

 Gordon Hamilton

 Celicourt Communications (Financial PR)

 Mark Antelme                                       Tel: +44 20 7770 6424

 Jimmy Lea

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRNKDBKPBKKOOD